These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1252 related items for PubMed ID: 26277091

  • 1. The Effect of Bleeding Risk and Frailty Status on Anticoagulation Patterns in Octogenarians With Atrial Fibrillation: The FRAIL-AF Study.
    Lefebvre MC, St-Onge M, Glazer-Cavanagh M, Bell L, Kha Nguyen JN, Viet-Quoc Nguyen P, Tannenbaum C.
    Can J Cardiol; 2016 Feb; 32(2):169-76. PubMed ID: 26277091
    [Abstract] [Full Text] [Related]

  • 2. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V, Marín F, Manzano-Fernández S, Gallego P, Vílchez JA, Valdés M, Vicente V, Lip GY.
    J Am Coll Cardiol; 2013 Dec 10; 62(23):2199-204. PubMed ID: 24055744
    [Abstract] [Full Text] [Related]

  • 3. Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) score.
    Lip GY, Frison L, Halperin JL, Lane DA.
    J Am Coll Cardiol; 2011 Jan 11; 57(2):173-80. PubMed ID: 21111555
    [Abstract] [Full Text] [Related]

  • 4. Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation.
    Gallego P, Roldán V, Torregrosa JM, Gálvez J, Valdés M, Vicente V, Marín F, Lip GY.
    Circ Arrhythm Electrophysiol; 2012 Apr 11; 5(2):312-8. PubMed ID: 22319005
    [Abstract] [Full Text] [Related]

  • 5. Comparison of HAS-BLED and HAS-BED Versus CHADS2 and CHA2DS2VASC Stroke and Bleeding Scores in Patients With Atrial Fibrillation.
    Poli D, Antonucci E, Pengo V, Testa S, Palareti G.
    Am J Cardiol; 2017 Apr 01; 119(7):1012-1016. PubMed ID: 28237286
    [Abstract] [Full Text] [Related]

  • 6. Stroke and bleeding risk co-distribution in real-world patients with atrial fibrillation: the Euro Heart Survey.
    Marcucci M, Lip GY, Nieuwlaat R, Pisters R, Crijns HJ, Iorio A.
    Am J Med; 2014 Oct 01; 127(10):979-986.e2. PubMed ID: 24838192
    [Abstract] [Full Text] [Related]

  • 7. Assessing the Appropriateness of Oral Anticoagulation for Atrial Fibrillation in Advanced Frailty: Use of Stroke and Bleeding Risk-Prediction Models.
    O'Caoimh R, Igras E, Ramesh A, Power B, O'Connor K, Liston R.
    J Frailty Aging; 2017 Oct 01; 6(1):46-52. PubMed ID: 28244558
    [Abstract] [Full Text] [Related]

  • 8. Time Trends of Aspirin and Warfarin Use on Stroke and Bleeding Events in Chinese Patients With New-Onset Atrial Fibrillation.
    Guo Y, Wang H, Tian Y, Wang Y, Lip GYH.
    Chest; 2015 Jul 01; 148(1):62-72. PubMed ID: 25501045
    [Abstract] [Full Text] [Related]

  • 9. Should we recommend oral anticoagulation therapy in patients with atrial fibrillation undergoing coronary artery stenting with a high HAS-BLED bleeding risk score?
    Ruiz-Nodar JM, Marín F, Roldán V, Valencia J, Manzano-Fernández S, Caballero L, Hurtado JA, Sogorb F, Valdés M, Lip GY.
    Circ Cardiovasc Interv; 2012 Aug 01; 5(4):459-66. PubMed ID: 22787018
    [Abstract] [Full Text] [Related]

  • 10. Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF).
    Rohla M, Weiss TW, Pecen L, Patti G, Siller-Matula JM, Schnabel RB, Schilling R, Kotecha D, Lucerna M, Huber K, De Caterina R, Kirchhof P.
    BMJ Open; 2019 Mar 30; 9(3):e022478. PubMed ID: 30928922
    [Abstract] [Full Text] [Related]

  • 11. Performance of the HEMORR(2)HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in patients with atrial fibrillation undergoing anticoagulation: the AMADEUS (evaluating the use of SR34006 compared to warfarin or acenocoumarol in patients with atrial fibrillation) study.
    Apostolakis S, Lane DA, Guo Y, Buller H, Lip GY.
    J Am Coll Cardiol; 2012 Aug 28; 60(9):861-7. PubMed ID: 22858389
    [Abstract] [Full Text] [Related]

  • 12. Assessment of the bleeding risk of anticoagulant treatment in non-severe frail octogenarians with atrial fibrillation.
    Shinohara M, Fujino T, Yao S, Yano K, Akitsu K, Koike H, Kinoshita T, Yuzawa H, Suzuki T, Kobayashi K, Ikeda T.
    J Cardiol; 2019 Jan 28; 73(1):7-13. PubMed ID: 29898863
    [Abstract] [Full Text] [Related]

  • 13. Development of a novel composite stroke and bleeding risk score in patients with atrial fibrillation: the AMADEUS Study.
    Lip GYH, Lane DA, Buller H, Apostolakis S.
    Chest; 2013 Dec 28; 144(6):1839-1847. PubMed ID: 24009027
    [Abstract] [Full Text] [Related]

  • 14. Oral anticoagulation in octogenarians with atrial fibrillation.
    Hugo GS, Figueiras-Graillet LM, Anguita M, Marín F, Bertomeu V, Roldán I, Ruiz M, Muñiz J, Martínez-Sellés M, FANTASIIA registry investigators (see Appendix).
    Int J Cardiol; 2016 Nov 15; 223():87-90. PubMed ID: 27532238
    [Abstract] [Full Text] [Related]

  • 15. Feasibility and safety of uninterrupted rivaroxaban for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry.
    Lakkireddy D, Reddy YM, Di Biase L, Vallakati A, Mansour MC, Santangeli P, Gangireddy S, Swarup V, Chalhoub F, Atkins D, Bommana S, Verma A, Sanchez JE, Burkhardt JD, Barrett CD, Baheiry S, Ruskin J, Reddy V, Natale A.
    J Am Coll Cardiol; 2014 Mar 18; 63(10):982-8. PubMed ID: 24412445
    [Abstract] [Full Text] [Related]

  • 16. Safety of percutaneous left atrial appendage closure with the Amplatzer cardiac plug in patients with atrial fibrillation and contraindications to anticoagulation.
    Wiebe J, Bertog S, Franke J, Wettstein O, Lehn K, Hofmann I, Vaskelyte L, Sievert H.
    Catheter Cardiovasc Interv; 2014 Apr 01; 83(5):796-802. PubMed ID: 24327462
    [Abstract] [Full Text] [Related]

  • 17. Real-World Clinical Characteristics and Treatment Patterns of Individuals Aged 80 and Older with Nonvalvular Atrial Fibrillation: Results from the ReAl-life Multicenter Survey Evaluating Stroke Study.
    Biteker M, Başaran Ö, Doğan V, Altun İ, Özpamuk Karadeniz F, Tekkesin Aİ, Çakıllı Y, Türkkan C, Hamidi M, Demir V, Gürsoy MO, Tek Öztürk M, Aksan G, Seyis S, Ballı M, Alıcı MH, Bozyel S.
    J Am Geriatr Soc; 2017 Aug 01; 65(8):1684-1690. PubMed ID: 28394435
    [Abstract] [Full Text] [Related]

  • 18. Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation).
    Patel MR, Hellkamp AS, Lokhnygina Y, Piccini JP, Zhang Z, Mohanty S, Singer DE, Hacke W, Breithardt G, Halperin JL, Hankey GJ, Becker RC, Nessel CC, Berkowitz SD, Califf RM, Fox KA, Mahaffey KW.
    J Am Coll Cardiol; 2013 Feb 12; 61(6):651-8. PubMed ID: 23391196
    [Abstract] [Full Text] [Related]

  • 19.
    Lopes RD, Crowley MJ, Shah BR, Melloni C, Wood KA, Chatterjee R, Povsic TJ, Dupre ME, Kong DF, de Barros e Silva PGM, dos Santos MHH, Armaganijan LV, Katz M, Kosinski A, McBroom AJ, Chobot MM, Gray R, Sanders GD.
    ; 2013 08 12. PubMed ID: 24049843
    [Abstract] [Full Text] [Related]

  • 20. Assessing the risk of bleeding in patients with atrial fibrillation: the Loire Valley Atrial Fibrillation project.
    Lip GY, Banerjee A, Lagrenade I, Lane DA, Taillandier S, Fauchier L.
    Circ Arrhythm Electrophysiol; 2012 Oct 12; 5(5):941-8. PubMed ID: 22923275
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 63.